The ACURATE neo aortic valve system is a self-expanding transcatheter device that was granted CE mark in and has since been widely adopted in the treatment of patients with severe aortic stenosis. The ACURATE neo can be used in a wide clinical spectrum, but there are some specific indications and anatomies where this device is particularly suitable. Recently, it was shown that, with appropriate patient screening, size selection, and optimised positioning, results can be improved substantially.
This review provides an overview of existing data and compiles a standardised manual of best practice for the implantation of this device based on both evidence and individual experience. It is characterised by a top-down deployment, which allows precise positioning and minimises flow obstruction during deployment 1.
Three stabilisation arches provide a better coaxial alignment, and the upper crown supports anchoring Figure 1. The transfemoral delivery system incorporates two knobs in the handle that can be turned to deploy the device in two steps. The smallest diameter of the delivery system is 15 Fr, increasing to 18 Fr at the site of the valve attachment. The ACURATE neo valve can be implanted via either transvascular or transapical access routes and has a dedicated transapical delivery system.
A recent study illustrated that results are considerably subject to appropriate patient screening, size selection, and optimised positioning 2. Figure 1. The purpose of this manuscript is to review the growing amount of clinical data on the ACURATE neo and to present a sophisticated approach for sizing and patient selection by highlighting suitable anatomies and indications.
Moreover, we aim to provide a best practice manual going through each procedural step of transfemoral implantation based on insights from experienced operators. Procedural success was At 30 days, all-cause mortality was 3. The purpose of this prospective, international registry was to demonstrate the efficacy and safety of the ACURATE neo in a real-world setting 4.
